Sign In
Buy GERN
$1.16
-0.0100 (-0.85%)
At Close: Jun 03, 2026
Geron (NASDAQ:GERN) Earns Buy Rating from Needham & Company LLC
03:44am, Thursday, 18'th Jun 2020
Geron (NASDAQ:GERN)‘s stock had its “buy” rating reaffirmed by stock analysts at Needham & Company LLC in a report released on Wednesday, TipRanks reports. They currently have a $3.00 target pri
Geron (GERN) Gets a Buy Rating from Needham - Markets
06:37pm, Wednesday, 17'th Jun 2020
In a report released today, Chad Messer from Needham reiterated a Buy rating on Geron (GERN – Research Report), with
Analyzing Polarityte (NASDAQ:PTE) & Halozyme Therapeutics (NASDAQ:HALO)
03:18am, Sunday, 14'th Jun 2020
Polarityte (NASDAQ:PTE) and Halozyme Therapeutics (NASDAQ:HALO) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the first randomised Phase 3 study investigating the subcut
Xconomy: Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More
01:57pm, Friday, 12'th Jun 2020
At the start of 2020 thousands of biotechies anticipated spending the second week of June in San Diego, hobnobbing at the annual conference hosted by the
Geron Reports Four Imetelstat Data Presentations at Virtual Edition of the European Hematology Association (EHA) Annual Congress
12:30pm, Friday, 12'th Jun 2020
Geron Corporation (GERN), a late-stage clinical biopharmaceutical company, today announced that an oral presentation and three poster presentations of new clinical data and analyses related to imetels
AbbVie : and Genmab Announce Broad Oncology Collaboration | MarketScreener
03:00pm, Thursday, 11'th Jun 2020Moving Average Crossover Alert: Geron
01:04pm, Thursday, 11'th Jun 2020
Geron Corporation (GERN) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Xconomy: AbbVie Commits $750M to Genmab Bispecific Antibody Cancer Drug Deal
12:10am, Thursday, 11'th Jun 2020
In one of the largest oncology partnerships ever, AbbVie and Genmab are teaming up to accelerate development and commercialization of three of the Danish
Dynavax Closes Enrollment in Renal Disease Study on Heplisav-B
01:30pm, Wednesday, 10'th Jun 2020
Dynavax (DVAX) is developing its hepatitis B vaccine, Heplisav-B, in patients with end-stage renal disease undergoing hemodialysis in a phase I study.
Top Ranked Momentum Stocks to Buy for June 9th
01:44pm, Tuesday, 09'th Jun 2020
Top Ranked Momentum Stocks to Buy for June 9th
How Geron Corporation (GERN) Stock Stands Out in a Strong Industry
12:40pm, Tuesday, 09'th Jun 2020
Geron Corporation (GERN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Legend Biotech Announces Three New Appointments to the Board of Directors
12:00am, Tuesday, 09'th Jun 2020
Legend Biotech (NASDAQ: LEGN) announced today that it has appointed Dr. Corazon (Corsee) Dating Sanders, Dr. Darren Ji, and Mr. Philip Yau to the comp
Moving Too Fast In Data Science Is Not The Way Forward, Says Saurabh Jha, Director – Data Science At Dell
02:30am, Monday, 08'th Jun 2020
Analytics India Magazine got in touch with Saurabh Jha, Director – Data Science at Dell, for our weekly column My Journey In Data Science. Saurabh has over 13 years of experience spread across data
